cin been rapid, revolutionary development of genomic tech- ever, despite 10 years of discussions there remains a lack Slade et al. Genome Medicine (2015) 7:18 DOI 10.1186/s13073-015-0128-4and cancer prevention in their relatives. This includes cancer risk estimation, gene testing, assistance with UK Full list of author information is available at the end of the articlenologies and extensive advances in knowledge of the impact of genomic variation on human disease. High-throughput DNA sequencing and analysis have been widely used in the research setting, but have not, thus of clear operational direction regarding the implementa-tion of increased gene testing within healthcare services. In the UK, specialist genetic services, including cancer...
Genomics medicine and molecular genetics are experiencing a surge of interest as well as a push for ...
Although the description and interpretation of cancer genetics has been at the core of cancer resear...
Genetic testing in patients with cancer; new developments About 5% of patients with cancer have a ca...
Genetic counselling is offered to patients with various hereditary cancers. At-risk family members c...
AbstractThe current and future applications of genomics to the practice of preventive oncology are b...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
Cancer therapy has historically been determined by a tumor’s tissue of origin. Now, thanks to advanc...
According to dogma in the information era of biomedicine, more DNA sequencing and protein profiling ...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
OBJECTIVE: Genomics is rapidly changing treatment paradigms for cancers, obligating oncologists to h...
Approximately 5 to 10% of all cancers are based on a hereditary predisposition. It is important to d...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
Genomics medicine and molecular genetics are experiencing a surge of interest as well as a push for ...
Although the description and interpretation of cancer genetics has been at the core of cancer resear...
Genetic testing in patients with cancer; new developments About 5% of patients with cancer have a ca...
Genetic counselling is offered to patients with various hereditary cancers. At-risk family members c...
AbstractThe current and future applications of genomics to the practice of preventive oncology are b...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
The identification of individuals carrying cancer susceptibility genetic variants could be improved ...
Cancer therapy has historically been determined by a tumor’s tissue of origin. Now, thanks to advanc...
According to dogma in the information era of biomedicine, more DNA sequencing and protein profiling ...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
OBJECTIVE: Genomics is rapidly changing treatment paradigms for cancers, obligating oncologists to h...
Approximately 5 to 10% of all cancers are based on a hereditary predisposition. It is important to d...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
Genomics medicine and molecular genetics are experiencing a surge of interest as well as a push for ...
Although the description and interpretation of cancer genetics has been at the core of cancer resear...
Genetic testing in patients with cancer; new developments About 5% of patients with cancer have a ca...